Ophthalmic epidemiology in Europe: the “European Eye Epidemiology” (E3) consortium

Archive ouverte

Delcourt, Cécile | Korobelnik, Jean-François | Buitendijk, Gabriëlle H. S. | Foster, Paul J. | Hammond, Christopher J. | Piermarocchi, Stefano | Peto, Tunde | Jansonius, Nomdo | Mirshahi, Alireza | Hogg, Ruth E. | Brétillon, Lionel | Topouzis, Fotis | Deak, Gabor | Souied, Eric H. | Creuzot-Garcher, Catherine | Sahel, José | Daien, Vincent | Lehtimäki, Terho | Hense, Hans-Werner | Prokofyeva, Elena | Oexle, Konrad | Rahi, Jugnoo S. | Cumberland, Phillippa M. | Bertelsen, Geir | Hoyng, Carel | Bergen, Arthur | Silva, Rufino | Wolf, Sebastian | Lotery, Andrew | Chakravarthy, Usha | Fletcher, Astrid | Klaver, Caroline C. W.

Edité par CCSD ; Springer Verlag -

GroupAuthor(s): On behalf of the European Eye Epidemiology (E3) consortium. International audience. The European Eye Epidemiology (E3) consortium is a recently formed consortium of 29 groups from 12 European countries. It already comprises 21 population-based studies and 20 other studies (case-control, cases only, randomized trials), providing ophthalmological data on approximately 170,000 European participants. The aim of the consortium is to promote and sustain collaboration and sharing of data and knowledge in the field of ophthalmic epidemiology in Europe, with particular focus on the harmonization of methods for future research, estimation and projection of frequency and impact of visual outcomes in European populations (including temporal trends and European subregions), identification of risk factors and pathways for eye diseases (lifestyle, vascular and metabolic factors, genetics, epigenetics and biomarkers) and development and validation of prediction models for eye diseases. Coordinating these existing data will allow a detailed study of the risk factors and consequences of eye diseases and visual impairment, including study of international geographical variation which is not possible in individual studies. It is expected that collaborative work on these existing data will provide additional knowledge, despite the fact that the risk factors and the methods for collecting them differ somewhat among the participating studies. Most studies also include biobanks of various biological samples, which will enable identification of biomarkers to detect and predict occurrence and progression of eye diseases. This article outlines the rationale of the consortium, its design and presents a summary of the methodology.

Suggestions

Du même auteur

Systemic and Ocular Determinants of Peripapillary Retinal Nerve Fiber Layer Thickness Measurements in the European Eye Epidemiology (E3) Population

Archive ouverte | Breteler, Monique | CCSD

International audience. PURPOSE:To investigate systemic and ocular determinants of peripapillary retinal nerve fiber layer thickness (pRNFLT) in the European population.DESIGN:Cross-sectional meta-analysis.PARTICIPA...

The Decreasing Prevalence of Nonrefractive Visual Impairment in Older Europeans

Archive ouverte | Delcourt, Cécile | CCSD

Authors are on the European Eye Epidemiology (E3) Consortium. Presented at: Association for Research in Vision and Ophthalmology Annual Meeting, May 2014, Orlando, Florida (United States). Manuscript no. 2017-1933. Supplemental ma...

Prevalence of age-related macular degeneration in Europe

Archive ouverte | Colijn, Johanna M. | CCSD

Manuscript no. 2016-1147 Supplemental material is available at www.aaojournal.org/. International audience. [u]Purpose:[/u] Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of Europe...

Chargement des enrichissements...